Evidence map›Paper›PMID 29873010›Full record

ReviewPain and therapy2018

A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac.

Fabiola Atzeni, Ignazio Francesco Masala, Piercarlo Sarzi-Puttini

Open access · goldAbstract readReview
In one paragraph

Review in Pain and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Article
  3. Targeting prostaglandin ENature communications · 2025
    Article
  4. Review
  5. Efficacy of Phlai (Life (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Early experience with diclofenac topical gel for moderate to severe postablation phlebitis.Journal of vascular surgery. Venous and lymphatic disorders · 2025
    Article
  8. Long Duration Continuous Ultrasound with Diclofenac Sodium Enhances Recovery from Sprains and Strains.International journal on physical medication & rehabilitation · 2025
    Article
  9. Article
  10. Article
  11. International journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Fabiola AtzeniRheumatology Unit, University of Messina, Messina, Italy. atzenifabiola@hotmail.com.
Ignazio Francesco MasalaOrthopedic and Trauma Unit, Santissima Trinità Hospital, Cagliari, Italy.
Piercarlo Sarzi-PuttiniRheumatology Unit, L. Sacco University Hospital, Milan, Italy.
Luigi Sacco Hospital · ITSantissima Trinità · ITUniversity of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diclofenac is widely used to manage chronic inflammatory and degenerative joint diseases such as osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis, and extra-articular rheumatism. Its various mechanisms of action make it particularly effective in treating nociceptive pain, but it is also an alternative for treating spinal and chronic central pain. Osteoarthritis and rheumatoid arthritis are the most frequently encountered arthritic conditions in adults. The management of nociceptive pain requires a sequential hierarchical approach, with the initial NSAID treatment being characterized by the replacement of one drug with another, or complete discontinuation usually because of insufficient pain control. OA- and RA-related pain is complex and multifactorial, and due to physiological interactions between the signaling of the central and peripheral nervous systems. The mechanisms of action of diclofenac make it particularly effective in treating both nociceptive pain and chronic central pain. This review underlines the mechanisms of diclofenac involved in chronic and acute joint pain, the most relevant adverse events.

Indexed as

Chronic painDiclofenacMusculoskeletal painNSAIDsSpinal pain

Identifiers

PMID29873010
PMCPMC6251833
OpenAlexW2806781498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.